Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in Transplantation

Retrieve available abstracts of 248 articles:
HTML format

Single Articles

    July 2021
  1. SOGBE M, Lopez-Guerra D, Blanco-Fernandez G, Sangro B, et al
    Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: the Importance of a Wash-Out Period.
    Transplantation. 2021 Jul 19. pii: 00007890-900000000-95194.

  2. PATRONO D, Zanierato M, Avolio AW, Romagnoli R, et al
    Different Timing of Cholangiocyte and Hepatocyte Damage in Liver Preservation: Time to Implement Donor Interventions and New Preservation Techniques to Prevent Ischemic-type Biliary Lesions.
    Transplantation. 2021;105:e77-e78.

    June 2021
  3. CENTONZE L, Lauterio A, De Carlis R, Ferla F, et al
    Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.
    Transplantation. 2021 Jun 23. pii: 00007890-900000000-95222.

  4. LIU XB, Liu H, Liu J, Cheung AKL, et al
    Cytomegalovirus Latency Exacerbated small-for-size Liver Graft Injury through Activation of CCL19/CCR7 in Hepatic Stellate Cells.
    Transplantation. 2021 Jun 2. doi: 10.1097/TP.0000000000003846.
    PubMed     Abstract available

  5. GORGEN A, Sapisochin G
    Re: Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
    Transplantation. 2021;105:e64.

  6. SERENARI M, Ravaioli M, Cescon M
    Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
    Transplantation. 2021;105:e63.

  7. PERI AM, Magro B, van den Bogaart L, Dalla Pria A, et al
    Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19.
    Transplantation. 2021;105:e65-e67.

    March 2021
  8. YAMADA M, Funaki T, Shoji K, Miyairi I, et al
    Do Not Delay: Safe Operation for Pediatric Living-donor Liver Transplantation Programs in the COVID-19 Era.
    Transplantation. 2021;105:e39-e40.

  9. WEISS E, Giabicani M, Saner F
    Do Liver Transplantation Criteria Differ According to the Type of Donor and the Severity of the Recipient?
    Transplantation. 2021;105:e32.

  10. XUE Y, Liu H, Yang XX, Pang L, et al
    Inhibition of Carnitine Palmitoyltransferase 1A Aggravates Fatty Liver Graft Injury via Promoting Mitochondrial Permeability Transition.
    Transplantation. 2021;105:550-560.
    PubMed     Abstract available

    February 2021
  11. HAN S, Cho J, Wi W, Lee KW, et al
    Sex difference in the tolerance of hepatic ischemia-reperfusion injury and hepatic estrogen receptor expression according to age and macrosteatosis in healthy living liver donors.
    Transplantation. 2021 Feb 22. doi: 10.1097/TP.0000000000003705.
    PubMed     Abstract available

  12. SHAKED O, Demetris J, Levitsky J, Feng S, et al
    Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003681.
    PubMed     Abstract available

    January 2021
  13. KING EA, Brennan DC
    The Science Is Only as Good as the Data: The Case of Fontan-associated Liver Disease.
    Transplantation. 2021;105:23-24.

    December 2020
  14. CULLARO G, Rubin J, Mehta N, Yao F, et al
    Sex-Based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2020 Dec 14. doi: 10.1097/TP.0000000000003575.
    PubMed     Abstract available

  15. GOLDBERG DS, Vianna RM, Martin EF, Martin P, et al
    Simultaneous Liver Kidney Transplant in Elderly Patients With Chronic Kidney Disease: Is There an Appropriate Upper Age Cutoff?
    Transplantation. 2020;104:2538-2546.
    PubMed     Abstract available

  16. CARDINI B, Fodor M, Hermann M, Wieser V, et al
    Live Confocal Imaging as a Novel Tool to Assess Liver Quality: Insights From a Murine Model.
    Transplantation. 2020;104:2528-2537.
    PubMed     Abstract available

    November 2020
  17. ZIOGAS IA, Giannis D, Economopoulos KP, Hayat MH, et al
    Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates.
    Transplantation. 2020 Nov 13. doi: 10.1097/TP.0000000000003539.
    PubMed     Abstract available

    October 2020
  18. HESSHEIMER AJ, Fondevila C
    Posttransplantation HCC Surveillance: Impact on Outcome or Byproduct of Biology?
    Transplantation. 2020;104:1997-1998.

  19. CAMPOS-VARELA I, Dodge JL, Berenguer M, Adam R, et al
    Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States.
    Transplantation. 2020;104:2078-2086.
    PubMed     Abstract available

    September 2020
  20. HSU YC, Yu IS, Tsai YF, Wu YM, et al
    A Pre-conditioning Strategy to Augment Retention and Engraftment Rate of Donor Cells during Hepatocyte Transplantation.
    Transplantation. 2020 Sep 22. doi: 10.1097/TP.0000000000003461.
    PubMed     Abstract available

  21. EL-DOMIATY N, Saliba F, Vibert E, Karam V, et al
    Early versus Late Hepatocellular Carcinoma Recurrence after Transplantation: Predictive Factors, Patterns and Long-term Outcome.
    Transplantation. 2020 Sep 1. doi: 10.1097/TP.0000000000003434.
    PubMed     Abstract available

    August 2020
    Sorafenib for Hepatocellular Carcinoma Recurrence After Liver Transplant.
    Transplantation. 2020;104:e243.

  23. INVERNIZZI F, Iavarone M
    The Authors' Reply.
    Transplantation. 2020;104:e244.

  24. COUSIN VL, Rougemont AL, Rubbia-Brandt L, Wildhaber BE, et al
    Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric Recipients.
    Transplantation. 2020;104:1633-1643.
    PubMed     Abstract available

  25. MOGUL DB, Perito ER, Wood N, Mazariegos GV, et al
    Impact of Acuity Circles on Outcomes for Pediatric Liver Transplant Candidates.
    Transplantation. 2020;104:1627-1632.
    PubMed     Abstract available

  26. LU YG, Pan ZY, Zhang S, Lu YF, et al
    Living Donor Liver Transplantation in Children: Perioperative Risk Factors and a Nomogram for Prediction of Survival.
    Transplantation. 2020;104:1619-1626.
    PubMed     Abstract available

  27. JACKSON KR, Bowring MG, Holscher C, Haugen CE, et al
    Outcomes After Declining a Steatotic Donor Liver for Liver Transplant Candidates in the United States.
    Transplantation. 2020;104:1612-1618.
    PubMed     Abstract available

  28. JACKSON KR, Motter JD, Haugen CE, Long JJ, et al
    Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.
    Transplantation. 2020;104:1604-1611.
    PubMed     Abstract available

  29. LUNSFORD KE, Agopian VG, Yi SG, Nguyen DTM, et al
    Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver-Kidney Transplantation.
    Transplantation. 2020;104:1591-1603.
    PubMed     Abstract available

  30. CHADHA R, De Martin E, Kabacam G, Kirchner V, et al
    Proceedings of the 25th Annual Congress of the International Liver Transplantation Society.
    Transplantation. 2020;104:1560-1565.
    PubMed     Abstract available

    July 2020
  31. DE MARTIN E, Sapisochin G
    Predicting Liver Transplant Patient Outcomes. Is a Validated Model Enough?
    Transplantation. 2020 Jul 13. doi: 10.1097/TP.0000000000003354.

  32. MOLINARI M, Jorgensen D, Ayloo S, Dharmayan S, et al
    Preoperative Stratification of Liver Transplant Recipients: Validation of the LTRS.
    Transplantation. 2020 Jul 13. doi: 10.1097/TP.0000000000003353.
    PubMed     Abstract available

  33. OSWARI H, Rahayatri TH, Soedibyo S
    Pediatric Living Donor Liver Transplant in Indonesia's National Referral Hospital.
    Transplantation. 2020;104:1305-1307.

  34. HEIMBACH JK, Taner T
    To Thine Own Self Be True.
    Transplantation. 2020;104:1326-1327.

  35. MAZUMDER NR, Atiemo K, Daud A, Kho A, et al
    Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
    Transplantation. 2020;104:1413-1418.
    PubMed     Abstract available

    June 2020
  36. HONG SK, Yi NJ, Cho JH, Lee JM, et al
    Parietal Peritoneum as a Novel Substitute for Middle Hepatic Vein Reconstruction During Living Donor Liver Transplantation.
    Transplantation. 2020 Jun 15. doi: 10.1097/TP.0000000000003349.
    PubMed     Abstract available

  37. WEISS E, Saner F, Asrani SK, Biancofiore G, et al
    When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts.
    Transplantation. 2020 Jun 15. doi: 10.1097/TP.0000000000003364.
    PubMed     Abstract available

    In France, Socioeconomic Status does not Affect Outcomes for Liver Transplantation for Hepatocellular Carcinoma: Encouraging Results but -- We need the Rest of the Story.
    Transplantation. 2020 Jun 9. doi: 10.1097/TP.0000000000003341.

  39. SAPISOCHIN G, Hibi T, Ghobrial M, Man K, et al
    The ILTS Consensus Conference on Transplant Oncology: Setting the Stage.
    Transplantation. 2020;104:1119-1120.

    May 2020
  40. KOSHY AN, Farouque O, Cailes B, Ko J, et al
    Prediction of Perioperative Cardiovascular Events in Liver Transplantation.
    Transplantation. 2020 May 11. doi: 10.1097/TP.0000000000003306.
    PubMed     Abstract available

  41. KUSAKABE J, Hata K, Tamaki I, Tajima T, et al
    Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade.
    Transplantation. 2020 May 5. doi: 10.1097/TP.0000000000003302.
    PubMed     Abstract available

    April 2020
  42. RODRIGUEZ-PERALVAREZ M, Gomez-Bravo MA, Sanchez-Antolin G, De la Rosa G, et al
    Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation.
    Transplantation. 2020 Apr 27. doi: 10.1097/TP.0000000000003281.
    PubMed     Abstract available

  43. AMIN A, Molina A, Quach L, Ito T, et al
    Liver Transplantation in Patients with Pretransplant Aspergillus Colonization: Is It Safe To Proceed?
    Transplantation. 2020 Apr 13. doi: 10.1097/TP.0000000000003276.
    PubMed     Abstract available

  44. LERUT J, Lai Q
    Red Blood Cells' Prestorage Leukoreduction and Reduced Risk of Posttransplant Hepatocellular Cancer Recurrence: Another Piece of the Tumor-immune System Puzzle?
    Transplantation. 2020 Apr 6. doi: 10.1097/TP.0000000000003266.

  45. KWON JH, Han S, Jang JS, Lee KW, et al
    Decrease in the Risk of Post-Transplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.
    Transplantation. 2020 Apr 6. doi: 10.1097/TP.0000000000003265.
    PubMed     Abstract available

  46. RHU J, Kim JM, Choi GS, Kwon CHD, et al
    The Authors' Reply: Anatomical and Extra-Anatomical Hepatic Artery Reconstruction During Living Donor Liver Transplantation: Is It Reasonable to Classify This Way?
    Transplantation. 2020;104:e112-e113.

  47. KURAMITSU K, Fukumoto T, Egawa H, Ohdan H, et al
    A Multicenter Japanese Survey Assessing the Long-term Outcomes of Liver Retransplantation Using Living Donor Grafts.
    Transplantation. 2020;104:754-761.
    PubMed     Abstract available

    March 2020
  48. SADD CJ, Osman F, Li Z, Chybowski A, et al
    Long-term Outcomes and Survival in Moderate-Severe Portopulmonary Hypertension After Liver Transplant.
    Transplantation. 2020 Mar 30. doi: 10.1097/TP.0000000000003248.
    PubMed     Abstract available

  49. CAILES B, Koshy AN, Gow P, Weinberg L, et al
    Inducible Left Ventricular Outflow Tract Obstruction in Patients Undergoing Liver Transplantation: Prevalence, Predictors and Association With Cardiovascular Events.
    Transplantation. 2020 Mar 27. doi: 10.1097/TP.0000000000003245.
    PubMed     Abstract available

  50. BERENGUER M, Burra P, Ghobrial M, Hibi T, et al
    Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003196.
    PubMed     Abstract available

  51. HIBI T, Rela M, Eason J, Line PD, et al
    Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003118.
    PubMed     Abstract available

  52. MEHTA N, Bhangui P, Yao FY, Mazzaferro V, et al
    Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003174.

  53. SAPISOCHIN G, Javle M, Lerut J, Ohtsuka M, et al
    Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular-cholangiocarcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003212.
    PubMed     Abstract available

  54. RIZZARI MD, Safwan M, Sobolic M, Kitajima T, et al
    The Impact of Portal Vein Thrombosis on Liver Transplant Outcomes: Does Grade or Flow Rate Matter?
    Transplantation. 2020 Mar 18. doi: 10.1097/TP.0000000000003235.
    PubMed     Abstract available

  55. HENSON JB, Wilder JM, Kappus MR, Barbas AS, et al
    Transplant Outcomes in Older Patients with Nonalcoholic Steatohepatitis Compared to Alcohol-Related Liver Disease and Hepatitis C.
    Transplantation. 2020 Mar 6. doi: 10.1097/TP.0000000000003219.
    PubMed     Abstract available

  56. ROSENBLATT R, Verna EC
    Cystatin C: The answer or a call for better kidney biomarkers in cirrhosis?
    Transplantation. 2020 Mar 6. doi: 10.1097/TP.0000000000003223.

  57. MAURO E, Crespo G, Martinez-Garmendia A, Gutierrez-Acevedo MN, et al
    Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Transplantation. 2020 Mar 6. doi: 10.1097/TP.0000000000003222.
    PubMed     Abstract available

  58. WESTERKAMP AC, Fujiyoshi M, Ottens PJ, Nijsten MWN, et al
    Metformin preconditioning improves hepatobiliary function and reduces injury in a rat model of normothermic machine perfusion and orthotopic transplantation.
    Transplantation. 2020 Mar 2. doi: 10.1097/TP.0000000000003216.
    PubMed     Abstract available

  59. NORDSTROM J, Lundgren M, Jorns C, Fischler B, et al
    First European Case of Simultaneous Liver and Pancreas Transplantation as Treatment of Wolcott-Rallison Syndrome in a Small Child.
    Transplantation. 2020;104:522-525.
    PubMed     Abstract available

    February 2020
  60. KOLLMANN D, Linares-Cervantes I, Ganesh S, Rosales R, et al
    Normothermic Ex Vivo Liver Perfusion Prevents Intrahepatic Platelet Sequestration After Liver Transplantation.
    Transplantation. 2020 Feb 21. doi: 10.1097/TP.0000000000003194.
    PubMed     Abstract available

  61. SOIN AS, Bhangui P, Kataria T, Baijal SS, et al
    Experience With LDLT in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging.
    Transplantation. 2020 Feb 6. doi: 10.1097/TP.0000000000003162.
    PubMed     Abstract available

  62. CONGLY SE, Brownfield KA
    Distinguishing Between Sex and Gender Is Critical for Research in Transplantation.
    Transplantation. 2020;104:e57.

  63. MCELROY L, Likhitsup A, Sabeed N, Hassan A, et al
    Re: Distinguishing Between Sex and Gender Is Critical for Research in Transplantation.
    Transplantation. 2020;104:e58.

  64. MAZUMDER NR, Atiemo K, Kappus M, Cullaro G, et al
    A Comprehensive Review of Outcome Predictors in Low MELD Patients.
    Transplantation. 2020;104:242-250.
    PubMed     Abstract available

  65. BABABEKOV YJ, Hung YC, Chang DC, Rickert CG, et al
    Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?
    Transplantation. 2020;104:280-284.
    PubMed     Abstract available

  66. BHANGUI P, Sah J, Choudhary N, Gautam D, et al
    Safe Use of Right Lobe Live Donor Livers With up to 20% Macrovesicular Steatosis Without Compromising Donor Safety and Recipient Outcome.
    Transplantation. 2020;104:308-316.
    PubMed     Abstract available

    January 2020
  67. GORGEN A, Galvin Z, Huang AC, Vinaixa C, et al
    The Impact of Direct Acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.: An International Multicenter Study.
    Transplantation. 2020 Jan 16. doi: 10.1097/TP.0000000000003115.
    PubMed     Abstract available

  68. LEE DD, Sapisochin G, Mehta N, Gorgen A, et al
    Surveillance for HCC after Liver Transplantation: Increased monitoring may yield aggressive treatment options and improved postrecurrence survival.
    Transplantation. 2020 Jan 13. doi: 10.1097/TP.0000000000003117.
    PubMed     Abstract available

    December 2019
  69. ZHANG BH, Cai YS, Lv T, Yang JY, et al
    Anatomical and Extra-Anatomical Hepatic Artery Reconstruction During Living Donor Liver Transplantation: Is It Reasonable to Classify This Way?
    Transplantation. 2019 Dec 3. doi: 10.1097/TP.0000000000003072.

    November 2019
  70. TANER T, Martins PN, Ling Q, Ng KT, et al
    What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2019? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.
    Transplantation. 2019 Nov 20. doi: 10.1097/TP.0000000000003058.
    PubMed     Abstract available

    October 2019
  71. CAUCHY F, Vibert E, Cherqui D, Perdigao F, et al
    Liver retransplantation associated with kidney transplantation for end stage liver graft disease and renal insufficiency: a morbid procedure on a unique subgroup of patients.
    Transplantation. 2019 Oct 23. doi: 10.1097/TP.0000000000003035.
    PubMed     Abstract available

    Avoiding dual graft loss in simultaneous liver retransplantation and primary kidney transplantation.
    Transplantation. 2019 Oct 22. doi: 10.1097/TP.0000000000003036.

  73. VERNA EC, Connelly C, Dove LM, Adem P, et al
    Center-Related Bias in MELD Scores Within a Liver Transplant UNOS Region: A Call for Standardization.
    Transplantation. 2019 Oct 22. doi: 10.1097/TP.0000000000003031.
    PubMed     Abstract available

  74. CARRIER FM, Chasse M, Sylvestre MP, Girard M, et al
    Effects of intraoperative fluid balance during liver transplantation on postoperative acute kidney injury: an observational cohort study.
    Transplantation. 2019 Oct 21. doi: 10.1097/TP.0000000000002998.
    PubMed     Abstract available

    September 2019
  75. BRAHMBHATT M, Prenner S, Bittermann T
    Liver transplantation for hepatic epithelioid hemangioendothelioma is facilitated by exception points with acceptable long-term outcomes.
    Transplantation. 2019 Sep 30. doi: 10.1097/TP.0000000000002982.
    PubMed     Abstract available

  76. LEE E, Sarkar M, Dodge J, Kohi M, et al
    Shorter Height is Associated with Lower Probability of Liver Transplantation in Patients with Hepatocellular Carcinoma.
    Transplantation. 2019 Sep 30. doi: 10.1097/TP.0000000000002975.
    PubMed     Abstract available

  77. NORTHUP PG, Intagliata NM, Davis JPE, Argo CK, et al
    Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.
    Transplantation. 2019 Sep 30. doi: 10.1097/TP.0000000000002990.
    PubMed     Abstract available

  78. DAGAN A, Choudhury RA, Yaffe H, Yoeli D, et al
    Offspring vs. Non Offspring to Parent Living Donor Liver Transplantation: Does Donor Relationship Matter?
    Transplantation. 2019 Sep 19. doi: 10.1097/TP.0000000000002977.
    PubMed     Abstract available

  79. BROWN S, Savva Y, Barth R, LaMattina J, et al
    Multiple regional listing increases liver transplant rates for those with MELD score less than 15.
    Transplantation. 2019 Sep 18. doi: 10.1097/TP.0000000000002965.
    PubMed     Abstract available

  80. INVERNIZZI F, Iavarone M, Zavaglia C, Mazza S, et al
    Transplantation. 2019 Sep 9. doi: 10.1097/TP.0000000000002955.
    PubMed     Abstract available

  81. SANDAL S, Chen T, Cantarovich M
    The Challenges with the Cardiac Evaluation of Liver and Kidney Transplant Candidates.
    Transplantation. 2019 Sep 3. doi: 10.1097/TP.0000000000002951.
    PubMed     Abstract available

    August 2019
  82. WU DA, Robb ML, Forsythe JLR, Bradley C, et al
    Recipient Comorbidity and Survival Outcomes after Kidney Transplantation: a UK-wide Prospective Cohort Study.
    Transplantation. 2019 Aug 19. doi: 10.1097/TP.0000000000002931.
    PubMed     Abstract available

  83. SAEED N, Glass L, Sharma P, Shannon C, et al
    Incidence and Risks for Non Alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Review and Meta-analysis.
    Transplantation. 2019 Aug 12. doi: 10.1097/TP.0000000000002916.
    PubMed     Abstract available

  84. WEEKS SR, Luo X, Haugen CE, Ottmann SE, et al
    Delayed graft function in simultaneous liver kidney transplantation.
    Transplantation. 2019 Aug 8. doi: 10.1097/TP.0000000000002908.
    PubMed     Abstract available

  85. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells: Retraction.
    Transplantation. 2019;103:1736.

  86. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences: Retraction.
    Transplantation. 2019;103:1736.

  87. Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience: Retraction.
    Transplantation. 2019;103:1736.

  88. LIU Y, Lu T, Zhang C, Xue Z, et al
    Pituitary Adenylate Cyclase-activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia-Reperfusion Injury.
    Transplantation. 2019;103:1639-1648.
    PubMed     Abstract available

    July 2019
  89. MIKOVA I, Neroldova M, Hubacek JA, Dlouha D, et al
    Transplantation. 2019 Jul 26. doi: 10.1097/TP.0000000000002876.
    PubMed     Abstract available

  90. SAKAMOTO S, Uchida H, Takeuchi I, Irie R, et al
    Sequential deceased donor intestine transplantation followed by living donor liver transplantation, also known as "hybrid intestine-liver transplantation".
    Transplantation. 2019 Jul 22. doi: 10.1097/TP.0000000000002883.

  91. VEROLET CM, Pittet LF, Wildhaber BE, McLin VA, et al
    Long-term seroprotection of varicella-zoster immunization in pediatric liver transplant recipients.
    Transplantation. 2019 Jul 15. doi: 10.1097/TP.0000000000002866.
    PubMed     Abstract available

  92. ALVAREZ-MERCADO AI, Negrete-Sanchez E, Gulfo J, Avalos de Leon CG, et al
    EGF-GH Axis in Rat Steatotic and Non-steatotic Liver Transplantation From Brain-dead Donors.
    Transplantation. 2019;103:1349-1359.
    PubMed     Abstract available

    June 2019
  93. XIE H, Zhang L, Guo D, Yang Z, et al
    Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death.
    Transplantation. 2019 Jun 25. doi: 10.1097/TP.0000000000002787.
    PubMed     Abstract available

  94. KANNEGANTI M, Mahmud N, Kaplan DE, Taddei TH, et al
    Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002816.
    PubMed     Abstract available

  95. BECKMANN S, Drent G, Ruppar T, Nikolic N, et al
    Body weight parameters are related to morbidity and mortality after liver transplantation - A systematic review and meta-analysis.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002811.
    PubMed     Abstract available

  96. MOLINARI M, Ayloo S, Tsung A, Jorgensen D, et al
    Prediction of Perioperative Mortality of Cadaveric Liver Transplant Recipients during their evaluations.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002810.
    PubMed     Abstract available

  97. MCELROY LM, Likhitsup A, Winder GS, Saeed N, et al
    Gender Disparities in Patients with Alcoholic Liver Disease Evaluated for Liver Transplantation.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002843.
    PubMed     Abstract available

  98. SCHIEFER J, Faybik P, Koch S, Tudor B, et al
    Glycocalyx damage within human liver grafts correlates with graft injury and postoperative graft function after orthotopic liver transplantation.
    Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002838.
    PubMed     Abstract available

  99. VICTOR DW 3RD, Monsour HP Jr, Boktour M, Lunsford K, et al
    Outcomes of Liver transplantation for hepatocellular carcinoma (HCC) beyond the University of California San Francisco (UCSF) criteria: a single center experience.
    Transplantation. 2019 Jun 18. doi: 10.1097/TP.0000000000002835.
    PubMed     Abstract available

    May 2019
  100. MORKANE CM, Kearney O, Bruce D, Melikian C, et al
    An outpatient hospital-based exercise training programme for patients with cirrhotic liver disease awaiting transplantation: a feasibility trial.
    Transplantation. 2019 May 20. doi: 10.1097/TP.0000000000002803.
    PubMed     Abstract available

  101. RODRIGUEZ-PERALVAREZ M, Guerrero M, De Luca L, Gros B, et al
    Area under trough concentrations of tacrolimus as a predictor of progressive renal impairment after liver transplantation.
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002760.
    PubMed     Abstract available

    Living Donor Liver Transplant in Alcohol-related Liver Disease: An Option Whose Time has Come.
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002784.

  103. BRAUN HJ, Dodge JL, Grab JD, Syed SM, et al
    Living Donor Liver Transplant for Alcoholic Liver Disease: Data from the Adult to Adult Living Donor Liver Transplantation Study (A2ALL).
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002783.
    PubMed     Abstract available

  104. CHENG XS, Goldhaber-Fiebert J, Tan JC, Chertow GM, et al
    Defining a willingness-to-transplant threshold in an era of organ scarcity: Simultaneous liver-kidney transplant as a case example.
    Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002788.
    PubMed     Abstract available

  105. ISSA F
    Proteomics Identifies New Therapeutic Targets of Early-stage Hepatocellular Carcinoma.
    Transplantation. 2019;103:855-856.

    April 2019
  106. KAMAL L, Yu JW, Reichman TW, Kang L, et al
    Impact of Induction Immunosuppression strategies in Simultaneous Liver Kidney Transplantation.
    Transplantation. 2019 Apr 22. doi: 10.1097/TP.0000000000002768.
    PubMed     Abstract available

  107. ARAVINTHAN AD, Fateen W, Doyle AC, Venkatachalapathy SV, et al
    The impact of preexisting and posttransplant diabetes mellitus on outcomes following liver transplantation.
    Transplantation. 2019 Apr 10. doi: 10.1097/TP.0000000000002757.
    PubMed     Abstract available

  108. LIU Y, Lu T, Zhang C, Xue Z, et al
    Pituitary Adenylate Cyclase-Activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia/Reperfusion Injury.
    Transplantation. 2019 Apr 8. doi: 10.1097/TP.0000000000002742.
    PubMed     Abstract available

  109. KUO SZ, Ahmad M, Dunn MA, Montano-Loza AJ, et al
    Sarcopenia Predicts Posttransplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation.
    Transplantation. 2019 Apr 8. doi: 10.1097/TP.0000000000002741.
    PubMed     Abstract available

  110. KAPPI T, Rabe H, Lingblom C, Hesselmar B, et al
    High frequency of concomitant food allergy development and autoantibody formation in children who have undergone liver transplantation.
    Transplantation. 2019 Apr 8. doi: 10.1097/TP.0000000000002751.
    PubMed     Abstract available

  111. ATIEMO K, Mazumder NR, Caicedo JC, Ganger D, et al
    The Hispanic Paradox in Patients with Liver Cirrhosis: Current Evidence from a Large Regional Retrospective Cohort Study.
    Transplantation. 2019 Apr 2. doi: 10.1097/TP.0000000000002733.
    PubMed     Abstract available

  112. EBADI M, Bhanji RA, Montano-Loza AJ
    Ethnic Disparities in the Prognosis of Cirrhosis.
    Transplantation. 2019 Apr 2. doi: 10.1097/TP.0000000000002734.

  113. IONESCU MI, Tillakaratne S, Hodson J, Gunson B, et al
    Normothermic Machine Perfusion Enhances Intraoperative Hepatocellular Synthetic Capacity: A Propensity-Score Matched Analysis.
    Transplantation. 2019 Apr 1. doi: 10.1097/TP.0000000000002720.
    PubMed     Abstract available

  114. SIDDIQUI MB, Patel S, Arshad T, Lee E, et al
    The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
    Transplantation. 2019 Apr 1. doi: 10.1097/TP.0000000000002714.
    PubMed     Abstract available

    March 2019
  115. GUSTAFSON E, Hamad OA, Deckmyn H, Barbu A, et al
    Exposure of von Willebrand factor on isolated hepatocytes promotes tethering of platelets to the cell surface.
    Transplantation. 2019 Mar 21. doi: 10.1097/TP.0000000000002707.
    PubMed     Abstract available

  116. TAPPER EB, Wexler R, Goldman E, Volk M, et al
    Constitutional Challenges to Liver Transplant Policy.
    Transplantation. 2019 Mar 5. doi: 10.1097/TP.0000000000002703.
    PubMed     Abstract available

  117. MALIK AK, Masson S, Allen E, Akyol M, et al
    Impact of regional organ sharing and allocation in the UK Northern Liver Alliance on waiting time to liver transplantation and waitlist survival.
    Transplantation. 2019 Mar 1. doi: 10.1097/TP.0000000000002687.
    PubMed     Abstract available

    February 2019
  118. BOWRING MG, Zhou S, Chow EKH, Massie AB, et al
    Geographic disparity in deceased-donor liver transplant rates following Share 35.
    Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002643.
    PubMed     Abstract available

  119. VAN DER VEER MAA, Nangrahary N, Hesselink DA, Erler NS, et al
    High Intra-Patient Variability in Tacrolimus Exposure Is Not Associated with Immune-Mediated Graft Injury after Liver Transplantation.
    Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002680.
    PubMed     Abstract available

  120. GORGEN A, Rosales R, Sadler E, Beecroft R, et al
    Patterns and Predictors of Mortality after Waitlist Dropout of Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.
    Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002616.
    PubMed     Abstract available

  121. MARTINS PN, Selzner M, Dayangac M, Ling Q, et al
    What is Hot and New in Basic Science in Liver Transplantation in 2018? Report of the Basic Science Committee of the International Liver Transplant Society.
    Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002617.

  122. QU W, Wei L, Zhu ZJ, Sun LY, et al
    Considerations for Use of Domino Cross-Auxiliary Liver Transplantation in Metabolic Liver Diseases: A review of Case Studies.
    Transplantation. 2019 Feb 18. doi: 10.1097/TP.0000000000002602.
    PubMed     Abstract available

  123. RHU J, Kim JM, Choi GS, Hyuck C, et al
    The impact of extra-anatomical hepatic artery reconstruction during living donor liver transplantation on biliary complications and graft and patient survival.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002601.
    PubMed     Abstract available

  124. KOC C, Akbulut S, Ozdemir F, Kose A, et al
    Analysis of Risk Factors Affecting the Development of Infection in Artificial Vascular Grafts Used for Reconstruction of Middle Hepatic Vein Tributaries in Living Donor Liver Transplantation.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002583.
    PubMed     Abstract available

  125. CHEN K, Sheng J, Ma B, Cao W, et al
    Suppression of hepatocellular carcinoma by mycophenolic acid in experimental models and in patients.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002647.
    PubMed     Abstract available

  126. WALLACE D, Walker K, Charman S, Suddle A, et al
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002559.
    PubMed     Abstract available

  127. SAFWAN M, Nwagu U, Collins K, Abouljoud M, et al
    Should all Status 1A patients be prioritized over high MELD patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002651.
    PubMed     Abstract available

    January 2019
  128. GEISSLER EK, Schlitt HJ
    Can mycophenolic acid-based immunosuppression benefit liver transplant patients with HCC?
    Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002648.

  129. CHANG SH, Wang M, Liu X, Alhamad T, et al
    Racial/ethnic disparities in access and outcomes of simultaneous liver-kidney transplant among liver transplant candidates with renal dysfunction in the United States.
    Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002574.
    PubMed     Abstract available

  130. JIMENEZ-CASTRO MB, Casillas-Ramirez A, Negrete-Sanchez E, Avalos-de Leon CG, et al
    Adipocytokines in Steatotic Liver Surgery/Transplantation.
    Transplantation. 2019;103:71-77.
    PubMed     Abstract available

  131. REIG M, Gambato M, Man NK, Roberts JP, et al
    Should Patients With NAFLD/NASH Be Surveyed for HCC?
    Transplantation. 2019;103:39-44.
    PubMed     Abstract available

  132. PIERANTONELLI I, Svegliati-Baroni G
    Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Transplantation. 2019;103:e1-e13.
    PubMed     Abstract available

  133. STEGGERDA JA, Kim IK, Malinoski D, Klein AS, et al
    Regional Variation in Utilization and Outcomes of Liver Allografts From Donors With High Body Mass Index and Graft Macrosteatosis: A Role for Liver Biopsy.
    Transplantation. 2019;103:122-130.
    PubMed     Abstract available

    November 2018
  134. KRISS M, Verna EC, Rosen HR, Lozupone CA, et al
    Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.
    Transplantation. 2018 Nov 30. doi: 10.1097/TP.0000000000002568.
    PubMed     Abstract available

  135. DE BOER J, Braat A, Putter H, de Vries E, et al
    Outcome of liver transplant patients with high urgent priority. Are we doing the right thing?
    Transplantation. 2018 Nov 21. doi: 10.1097/TP.0000000000002526.
    PubMed     Abstract available

  136. DE MARTIN E, Hessheimer A, Chadha R, Kabacam G, et al
    Report of the 24th Annual Congress of the International Liver Transplantation Society.
    Transplantation. 2018 Nov 19. doi: 10.1097/TP.0000000000002549.
    PubMed     Abstract available

  137. SHINGINA A, DeWitt PE, Dodge JL, Biggins SW, et al
    Future Trends in Demand for Liver Transplant: Birth-Cohort Effects among Patients with NASH and HCC.
    Transplantation. 2018 Nov 16. doi: 10.1097/TP.0000000000002497.
    PubMed     Abstract available

  138. BABABEKOV YJ, Hung YC, Rickert CG, Njoku FC, et al
    Health Literacy Burden Is Associated with Access to Liver Transplantation.
    Transplantation. 2018 Nov 13. doi: 10.1097/TP.0000000000002536.
    PubMed     Abstract available

  139. TAN PS, Muthiah MD, Koh T, Teoh YL, et al
    Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation.
    Transplantation. 2018 Nov 13. doi: 10.1097/TP.0000000000002532.
    PubMed     Abstract available

  140. Analysis of Differentially Expressed Proteins in Hepatocellular Carcinoma: Erratum.
    Transplantation. 2018 Nov 12. doi: 10.1097/TP.0000000000002534.

  141. LINARES I, Hamar M, Selzner N, Selzner M, et al
    Steatosis in Liver Transplantation: Current Limitations and Future Strategies.
    Transplantation. 2018 Nov 9. doi: 10.1097/TP.0000000000002466.
    PubMed     Abstract available

  142. MUSTIAN MN, Shelton BA, MacLennan PA, Reed RD, et al
    Ethnic and Age Disparities in Outcomes among Liver Transplant Waitlist Candidates.
    Transplantation. 2018 Nov 9. doi: 10.1097/TP.0000000000002523.
    PubMed     Abstract available

  143. PAUL S, Charlton M
    Liver Transplantation for Nonalcoholic Steatohepatitis: New Evidence of a Profound Increase Across Age Cohorts.
    Transplantation. 2018 Nov 5. doi: 10.1097/TP.0000000000002513.

    October 2018
  144. SINGH A, Fritze D, Mansouri M, Lopez R, et al
    Characteristics and Outcomes of Liver Transplantation for Primary Biliary Cholangitis (PBC) in Young patients: Analysis of the United Network for Organ Sharing Database.
    Transplantation. 2018 Oct 30. doi: 10.1097/TP.0000000000002501.
    PubMed     Abstract available

  145. BURRA P, Berenguer M, Pomfret E
    The ILTS Consensus Conference on NAFLD/NASH and liver transplantation.
    Transplantation. 2018 Oct 26. doi: 10.1097/TP.0000000000002507.

  146. YOUNOSSI ZM, Marchesini G, Pinto-Cortez H, Petta S, et al
    Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Transplantation. 2018 Oct 17. doi: 10.1097/TP.0000000000002484.
    PubMed     Abstract available

  147. GERMANI G, Laryea M, Rubbia-Brandt L, Egawa H, et al
    Management of Recurrent and De Novo NAFLD/NASH after Liver Transplantation.
    Transplantation. 2018 Oct 17. doi: 10.1097/TP.0000000000002485.
    PubMed     Abstract available

  148. MARA C, Pietro V, Mohamed R, Anil D, et al
    NAFLD and liver transplantation in children - Working group report from the ILTS single topic conference on NAFLD.
    Transplantation. 2018 Oct 16. doi: 10.1097/TP.0000000000002490.
    PubMed     Abstract available

  149. DOSHI SD, Wood L, Abt PL, Olthoff KM, et al
    Outcomes of living donor liver transplantation using grafts heterozygous for alpha-1 antitrypsin gene mutations.
    Transplantation. 2018 Oct 16. doi: 10.1097/TP.0000000000002493.
    PubMed     Abstract available

  150. IYER VN, Saberi B, Heimbach JK, Larson JJ, et al
    Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia In the United States.
    Transplantation. 2018 Oct 16. doi: 10.1097/TP.0000000000002491.
    PubMed     Abstract available

  151. SOIN AS, Chaudhary RJ, Pahari H, Pomfret EA, et al
    A worldwide survey of Live liver donor selection policies at 24 centers with a combined experience of 19 009 adult living donor liver transplants.
    Transplantation. 2018 Oct 11. doi: 10.1097/TP.0000000000002475.
    PubMed     Abstract available

  152. RATZIU V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G, et al
    Recommendations for management and treatment of nonalcoholic steatohepatitis.
    Transplantation. 2018 Oct 8. doi: 10.1097/TP.0000000000002483.
    PubMed     Abstract available

  153. CHOLANKERIL G, Gadiparthi C, Yoo ER, Dennis BB, et al
    Temporal Trends Associated with the Rise in Alcoholic Liver Disease Related Liver Transplantation in the United States.
    Transplantation. 2018 Oct 8. doi: 10.1097/TP.0000000000002471.
    PubMed     Abstract available

  154. LU WY, Forbes SJ
    Telomerase Activity Links to Regenerative Capacity of Hepatocytes.
    Transplantation. 2018;102:1587-1588.

    August 2018
  155. TSOCHATZIS E, Coilly A, Nadalin S, Levistky J, et al
    International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation.
    Transplantation. 2018 Aug 27. doi: 10.1097/TP.0000000000002433.
    PubMed     Abstract available

  156. CULLARO G, Hirose R, Lai JC
    Changes in Simultaneous Liver Kidney Transplant Allocation Policy May Impact Post Liver Transplant Outcomes.
    Transplantation. 2018 Aug 6. doi: 10.1097/TP.0000000000002403.
    PubMed     Abstract available

  157. YOO S, Jang EJ, Yi NJ, Kim GH, et al
    Effect of institutional case volume on in-hospital mortality after living donor liver transplantation: Analysis of 7073 cases between 2007 and 2016 in Korea.
    Transplantation. 2018 Aug 6. doi: 10.1097/TP.0000000000002394.
    PubMed     Abstract available

  158. MOON JI, Schiano TD, Burnham A, Lam K, et al
    Small-for-size Syndrome Does Not Occur in Intestinal Transplantation Without Liver Containing Grafts.
    Transplantation. 2018;102:1300-1306.
    PubMed     Abstract available

    July 2018
  159. GADSDEN MM, Goldberg DS
    Hepatic Dysfunction in Deceased Donors in the Age of the Opioid Epidemic.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002368.

  160. BARBIER L, Bucur P, Salame E
    Extended-criteria allografts a strategy to reduce waiting list mortality in selected hepatocellular carcinoma recipients.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002365.

  161. WALLEN MP, Woodward AJ, Hall A, Skinner TL, et al
    Poor cardiorespiratory fitness is a risk factor for sepsis in patients awaiting liver transplantation.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002360.
    PubMed     Abstract available

  162. NARAYANAN P, Mara K, Izzy M, Dierkhising R, et al
    Recurrent or De Novo Allograft Steatosis and Long-Term Outcomes After Liver Transplantation.
    Transplantation. 2018 Jul 10. doi: 10.1097/TP.0000000000002317.
    PubMed     Abstract available

  163. HEITS N, Brosch M, Herrmann A, Behrens R, et al
    Transplantation. 2018 Jul 9. doi: 10.1097/TP.0000000000002356.
    PubMed     Abstract available

  164. THULUVATH PJ, Hanish S, Savva Y
    Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared to Cryptogenic, Alcoholic or AIH Cirrhosis.
    Transplantation. 2018 Jul 5. doi: 10.1097/TP.0000000000002355.
    PubMed     Abstract available

  165. DOMEN J
    Minimally invasive transplantation of primary human hepatocyte inserts that facilitate vascularization.
    Transplantation. 2018 Jul 3. doi: 10.1097/TP.0000000000002331.

  166. CROOME KP, Mathur AK, Lee DD, Moss AA, et al
    Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.
    Transplantation. 2018;102:1108-1114.
    PubMed     Abstract available

  167. LEE KW, Han S, Lee S, Cha HH, et al
    Higher Risk of Posttransplant Liver Graft Failure in Male Recipients of Female Donor Grafts Might Not Be Due to Anastomotic Size Disparity.
    Transplantation. 2018;102:1115-1123.
    PubMed     Abstract available

    June 2018
  168. SEALE N, Ramaswamy S, Shih YR, Verma I, et al
    Macroporous dual compartment hydrogels for minimally invasive transplantation of primary human hepatocytes.
    Transplantation. 2018 Jun 18. doi: 10.1097/TP.0000000000002330.
    PubMed     Abstract available

  169. IMAI D, Yoshizumi T, Sakata K, Ikegami T, et al
    Long-term outcomes and risk factors after adult living donor liver transplantation.
    Transplantation. 2018 Jun 13. doi: 10.1097/TP.0000000000002324.
    PubMed     Abstract available

  170. MIYAAKI H, Miuma S, Taura N, Shibata H, et al
    Risk factors and clinical course for liver steatosis or nonalcoholic steatohepatitis after living donor liver transplantation.
    Transplantation. 2018 Jun 11. doi: 10.1097/TP.0000000000002319.
    PubMed     Abstract available

    May 2018
  171. DURAND F, Francoz C, Asrani SK, Khemichian S, et al
    Acute Kidney Injury after Liver Transplantation.
    Transplantation. 2018 May 29. doi: 10.1097/TP.0000000000002305.
    PubMed     Abstract available

  172. LI F, Jiao A, Li X, Zhang C, et al
    Survival and Metabolic Function of Syngeneic Mouse Islet Grafts Transplanted into the Hepatic Sinus-tract.
    Transplantation. 2018 May 22. doi: 10.1097/TP.0000000000002289.
    PubMed     Abstract available

  173. RODRIGUEZ-PERALVAREZ M, Guerrero M, Barrera L, Ferrin G, et al
    Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation.
    Transplantation. 2018 May 11. doi: 10.1097/TP.0000000000002270.
    PubMed     Abstract available

  174. PARKER A, Karvellas CJ
    Coagulation Defects in the Cirrhotic Patient Undergoing Liver Transplantation.
    Transplantation. 2018 May 7. doi: 10.1097/TP.0000000000002273.
    PubMed     Abstract available

  175. MARCON F, Schlegel A, Bartlett DC, Kalisvaart M, et al
    Utilization of Declined Liver Grafts Yields Comparable Transplant Outcomes and Previous Decline Should Not Be a Deterrent to Graft Use.
    Transplantation. 2018;102:e211-e218.
    PubMed     Abstract available

    April 2018
  176. LIKHITSUP A, Helzberg JH, Alba LM, Larkin MK, et al
    Persistent Alpha-galactosidase A Deficiency following Simultaneous Liver-Kidney Transplantation in a Patient with Fabry Disease.
    Transplantation. 2018 Apr 24. doi: 10.1097/TP.0000000000002257.

  177. PERITO ER, Roll G, Dodge JL, Rhee S, et al
    Split liver transplantation and pediatric waitlist mortality in the United States: potential for improvement.
    Transplantation. 2018 Apr 21. doi: 10.1097/TP.0000000000002249.
    PubMed     Abstract available

  178. HOGEN R, Lo M, DiNorcia J, Ji L, et al
    More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma.
    Transplantation. 2018 Apr 18. doi: 10.1097/TP.0000000000002248.
    PubMed     Abstract available

  179. HONDA M, Sugawara Y, Kadohisa M, Shimata K, et al
    Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation.
    Transplantation. 2018 Apr 3. doi: 10.1097/TP.0000000000002197.
    PubMed     Abstract available

  180. ALLEN AM, Heimbach JK, Larson JJ, Mara KC, et al
    Reduced access to liver transplantation in women: role of height, MELD exception scores and renal function underestimation.
    Transplantation. 2018 Apr 3. doi: 10.1097/TP.0000000000002196.
    PubMed     Abstract available

    The Author's Reply.
    Transplantation. 2018;102:e189-e190.

    March 2018
  182. VANWAGNER LB, Montag S, Zhao L, Allen NB, et al
    Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment Following Liver Transplantation.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002175.
    PubMed     Abstract available

    February 2018
  183. KIM JM, Kwon CHD, Joh JW, Han S, et al
    ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Transplantation. 2018 Feb 28. doi: 10.1097/TP.0000000000002154.
    PubMed     Abstract available

  184. CHARLTON M, Levitsky J, Aqel B, O'Grady J, et al
    International Liver Transplant Society Consensus Statement on IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002147.

  185. RHU J, Kim JM, Choi GS, Kwon CHD, et al
    Validation of the alpha-fetoprotein model for hepatocellular carcinoma recurrence after transplantation in an Asian population.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002136.
    PubMed     Abstract available

  186. THULUVATH AJ, Chen PH, Thuluvath PJ, Kantsevoy S, et al
    Poor Survival after Retransplantation in NASH cirrhosis.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002135.
    PubMed     Abstract available

  187. ADELMANN D, Olmos A, Liu LL, Feiner JR, et al
    Intraoperative management of liver transplant patients without the routine use of renal replacement therapy.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002137.
    PubMed     Abstract available

  188. SHIRABE K, Eguchi S, Okajima H, Hasegawa K, et al
    Current status of surgical incisions used in donors during living related liver transplantation - a nationwide survey in Japan.
    Transplantation. 2018 Feb 9. doi: 10.1097/TP.0000000000002126.
    PubMed     Abstract available

  189. SAVALE L, Duclos-Vallee JC, Sitbon O
    Outcome of portopulmonary hypertension after liver transplantation: perhaps not so optimistic.
    Transplantation. 2018 Feb 2. doi: 10.1097/TP.0000000000002112.

    January 2018
  190. QUARELLO P, Tandoi F, Carraro F, Vassallo E, et al
    Successful sequential liver and haematopoietic stem cell transplantation in a child with CD40 ligand deficiency and Cryptosporidium-induced liver cirrhosis.
    Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002114.
    PubMed     Abstract available

  191. BHAT M, Mara K, Dierkhising R, Watt KD, et al
    Gender, Race and Disease Etiology Predict De Novo Malignancy Risk following Liver Transplantation: Insights for Future Individualized Cancer Screening Guidance.
    Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002113.
    PubMed     Abstract available

  192. GIARD JM, Mehta N, Dodge JL, Roberts JP, et al
    Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2018 Jan 17. doi: 10.1097/TP.0000000000002094.
    PubMed     Abstract available

  193. BEZINOVER D, Dirkmann D, Findlay J, Guta C, et al
    Perioperative Coagulation Management in Liver Transplant Recipients.
    Transplantation. 2018 Jan 15. doi: 10.1097/TP.0000000000002092.
    PubMed     Abstract available

  194. ECKER BL, Hoteit MA, Forde KA, Hsu CC, et al
    Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002056.
    PubMed     Abstract available

  195. SADLER EM, Mehta N, Bhat M, Ghanekar A, et al
    Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002043.
    PubMed     Abstract available

  196. YAO S, Yagi S, Uozumi R, Iida T, et al
    A high portal venous pressure gradient increases gut-related bacteremia and consequent early mortality after living donor liver transplantation.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002047.
    PubMed     Abstract available

  197. GIRETTI G, Barbier L, Bucur P, Marques F, et al
    Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation.
    Transplantation. 2018 Jan 2. doi: 10.1097/TP.0000000000002069.
    PubMed     Abstract available

    December 2017
  198. IANNELLI A, Schiavo L
    Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002065.

    The Author's Reply: Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002064.

  200. THULUVATH PJ, Hanish S, Savva Y
    Liver Transplantation in Cryptogenic Cirrhosis: Outcome comparisons between NASH, Alcoholic and AIH cirrhosis.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002030.
    PubMed     Abstract available

    November 2017
  201. PUCHADES L, Chau S, Dodson JA, Mohamad Y, et al
    Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Transplantation. 2017 Nov 20. doi: 10.1097/TP.0000000000002025.
    PubMed     Abstract available

  202. LI CX, Man K, Lo CM
    The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation.
    Transplantation. 2017;101:2665-2670.
    PubMed     Abstract available

  203. GREY ST, Issa F
    The 2017 Transplantation Awards: Recognizing a Landmark Clinical Trial and a Basic Science Discovery With Far-Reaching Implications.
    Transplantation. 2017;101:2655-2656.

    October 2017
  204. REYMOND M, Barbier L, Salame E, Besh C, et al
    Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Transplantation. 2017 Oct 26. doi: 10.1097/TP.0000000000001981.
    PubMed     Abstract available

  205. ZHU J, Chen PY, Frankel M, Selby RR, et al
    Contemporary Policies Regarding Alcohol and Marijuana use Among Liver Transplant Programs in the United States.
    Transplantation. 2017 Oct 10. doi: 10.1097/TP.0000000000001969.
    PubMed     Abstract available

  206. SPENGLER EK, O'Leary JG, Te HS, Rogal S, et al
    Liver Transplantation in the Obese Cirrhotic Patient.
    Transplantation. 2017;101:2288-2296.
    PubMed     Abstract available

  207. WENG J, Li W, Jia X, An W, et al
    Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
    Transplantation. 2017;101:2340-2348.
    PubMed     Abstract available

  208. O'LEARY JG, Demetris AJ, Philippe A, Freeman R, et al
    Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    Transplantation. 2017;101:2399-2409.
    PubMed     Abstract available

    September 2017
  209. WONG LL, Truong HP, Seto T, Lacar L, et al
    Marked decrease in urgent listing for liver transplantation over time: evolution of characteristics and outcomes of Status-1 liver transplantation.
    Transplantation. 2017 Sep 29. doi: 10.1097/TP.0000000000001967.
    PubMed     Abstract available

  210. CITRO A, Cantarelli E, Pellegrini S, Dugnani E, et al
    Antiinflammatory strategies in intrahepatic islet transplantation: a comparative study in preclinical models.
    Transplantation. 2017 Sep 8. doi: 10.1097/TP.0000000000001925.
    PubMed     Abstract available

  211. WEICHEN Z, Feibo L, Yufu Y, Yuanxing L, et al
    Isoglycyrrhizinate magnesium enhances hepatoprotective effect of FK506 on ischemia-reperfusion injury through HMGB1 inhibition in a rat model of liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001941.
    PubMed     Abstract available

  212. SNEIDERS D, Houwen T, Pengel LHM, Polak WG, et al
    Systematic review and meta-analysis of posttransplant hepatic artery and biliary complications in patients treated with transarterial chemoembolization before liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001936.
    PubMed     Abstract available

    August 2017
  213. CHARLTON M, Rinella M, Patel D, McCague K, et al
    Everolimus is Associated With Less Weight Gain Than Tacrolimus 2 Years Following Liver Transplantation: Results of a Randomized Multicenter Study.
    Transplantation. 2017 Aug 15. doi: 10.1097/TP.0000000000001913.
    PubMed     Abstract available

  214. DOSHI SD, Bittermann T, Schiano TD, Goldberg DS, et al
    Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.
    Transplantation. 2017;101:1838-1844.
    PubMed     Abstract available

  215. ICHAI P, Laurent-Bellue A, Saliba F, Moreau D, et al
    Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.
    Transplantation. 2017;101:1830-1837.
    PubMed     Abstract available

  216. STINE JG, Intagliata N, Northup PG, Caldwell SH, et al
    Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation: More Questions Than Answers?
    Transplantation. 2017;101:e281-e282.

    July 2017
  217. BOYLAN JM, Francois-Vaughan H, Gruppuso PA, Sanders JA, et al
    Engraftment and Repopulation Potential of Late Gestation Fetal Rat Hepatocytes.
    Transplantation. 2017 Jul 27. doi: 10.1097/TP.0000000000001882.
    PubMed     Abstract available

  218. LI Y, Ma D, Wang Z, Yang J, et al
    MicroRNA-155 Deficiency in Kupffer Cells Ameliorates Liver Ischemia-Reperfusion Injury in Mice.
    Transplantation. 2017;101:1600-1608.
    PubMed     Abstract available

  219. DUBROCK HM, Goldberg DS, Sussman NL, Bartolome SD, et al
    Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    Transplantation. 2017;101:1609-1615.
    PubMed     Abstract available

  220. JOCHMANS I, van Rosmalen M, Pirenne J, Samuel U, et al
    Adult Liver Allocation in Eurotransplant.
    Transplantation. 2017;101:1542-1550.
    PubMed     Abstract available

  221. DESCAMPS V, Brunet-Possenti F
    Human Herpesvirus 6 Reactivation in DRESS With Acute Liver Failure: A Missing Key Factor.
    Transplantation. 2017;101:e224-e225.

    June 2017
  222. KIM PT, Klintmalm GB
    Authors' Reply: Does low Hepatic Artery Flow Increase Rate of Biliary Strictures in Deceased Donor Liver Transplantation?
    Transplantation. 2017 Jun 21. doi: 10.1097/TP.0000000000001855.

  223. YI Z, Mayorga ME, Orman ES, Wheeler SB, et al
    Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Transplantation. 2017 Jun 20. doi: 10.1097/TP.0000000000001851.
    PubMed     Abstract available

    May 2017
  224. EMOND JC, Goodrich NP, Pomposelli JJ, Baker TB, et al
    Hepatic hemodynamics and portal flow modulation: The A2ALL experience.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001823.
    PubMed     Abstract available

  225. KENSINGER CD, Feurer ID, Karp SJ
    An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
    Transplantation. 2017 May 4. doi: 10.1097/TP.0000000000001812.
    PubMed     Abstract available

  226. CHENG XS, Stedman MR, Chertow GM, Kim WR, et al
    Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation.
    Transplantation. 2017;101:1111-1119.
    PubMed     Abstract available

    March 2017
  227. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Abstract available

  228. NEKRASOV V, Matsuoka L, Kaur N, Pita A, et al
    Improvement in the Outcomes of MELD >/= 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001738.
    PubMed     Abstract available

    February 2017
  229. PALUMBO T, Nakamura K, Lassman C, Kidani Y, et al
    Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
    Transplantation. 2017;101:322-331.
    PubMed     Abstract available

  230. REDDY MS, Rajalingam R, Rela M
    Revisiting APOLT for Metabolic Liver Disease: A New Look at an Old Idea.
    Transplantation. 2017;101:260-266.
    PubMed     Abstract available

    January 2017
  231. SATAPATHY SK, Vanatta JM, Helmick R, Flowers A, et al
    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001647.
    PubMed     Abstract available

  232. DEMARTINO ES, Cartin-Ceba R, Findlay JY, Heimbach JK, et al
    Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    Transplantation. 2017;101:101-106.
    PubMed     Abstract available

    August 2016
  233. MOHKAM K, Fanget F, Darnis B, Harbaoui B, et al
    Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.
    Transplantation. 2016.
    PubMed     Abstract available

  234. DE CARLIS L, De Carlis R, Lauterio A, Di Sandro S, et al
    Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time.
    Transplantation. 2016.

  235. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Abstract available

  236. CICALESE L, Shirafkan A, Jennings K, Zorzi D, et al
    Increased risk of death for patients on the waitlist for liver transplant residing at greater distance from specialized liver transplant centers in the USA.
    Transplantation. 2016.
    PubMed     Abstract available

  237. HART A, Schladt DP, Zeglin J, Pyke J, et al
    Predicting outcomes on the liver transplant waiting list in the United States: Accounting for large regional variation in organ availability and priority allocation points.
    Transplantation. 2016.
    PubMed     Abstract available

  238. MURALI AR, Chandra S, Stewart Z, Blazar BR, et al
    Graft versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Transplantation. 2016.
    PubMed     Abstract available

    July 2016
  239. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    PubMed     Abstract available

  240. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    PubMed     Abstract available

  241. SULLIVAN T, Weinberg A, Rana M, Patel G, et al
    The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Transplantation. 2016.
    PubMed     Abstract available

  242. POMPOSELLI JJ, Goodrich NP, Emond JC, Humar A, et al
    Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Transplantation. 2016;100:1490-9.
    PubMed     Abstract available

    June 2016
  243. HSU CC, Chen CL, Wang CC, Lin CC, et al
    Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Abstract available

  244. WANG CW, Feng S, Covinsky KE, Hayssen H, et al
    A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Transplantation. 2016.
    PubMed     Abstract available

  245. SALVALAGGIO PR, Seda Neto J, Alves JA, Fonseca EA, et al
    Consensus, Dilemmas, and Challenges in Living Donor Liver Transplantation in Latin America.
    Transplantation. 2016;100:1161-4.
    PubMed     Abstract available

    May 2016
  246. DEW MA, DiMartini AF, Ladner DP, Simpson MA, et al
    Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Transplantation. 2016.
    PubMed     Abstract available

    March 2016
  247. CAO Y, Shahrestani S, Chew HC, Crawford M, et al
    Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.
    Transplantation. 2016.
    PubMed     Abstract available

  248. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.